Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Background and aims In the non-metropolitan region of Brandenburg (Germany), which is characterized by high rates of cardiovascular diseases and underserved medical care, there is a lack of awareness regarding lipoprotein(a) [Lp(a)] as a risk factor. 3.95, p  = 0.003). vs. 45.8%; 17.6% vs. 13.9%, p  = 0.001). vs. 45.8%; 17.6%

Risk Factors 59

Risk Factors Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease 59

Frontiers in Cardiovascular Medicine

JUNE 26, 2024

Hypertension is a significant risk factor for cardiovascular and cerebrovascular diseases and has become a global public health concern. Although hypertension results from a combination of factors, the specific mechanism is still unclear.

Hypertension 52

Hypertension Cerebrovascular Disease Public Health Transplant 52

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2024

Introduction Myocardial injury in elderly Omicron variant patients is a leading cause of severe disease and death. This study focuses on elucidating the clinical characteristics and potential risk factors associated with myocardial injury in elderly patients infected with the Omicron variant.

Risk Factors 64

Risk Factors Laboratory Cerebrovascular Disease Coronary Artery Disease 64

Hypertension Journal

JANUARY 2, 2024

Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide.

Hypertension 40

Hypertension Blood Pressure Cerebrovascular Disease Risk Factors 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Lipoprotein(a) [Lp(a)] is a known risk factor for cardiovascular disease; however, its association with cerebrovascular disease is not as well established.Methods:Data from HCHS/SOL, a population-based cohort of Hispanics/Latinos, was utilized.

Cerebrovascular Disease 40

Cerebrovascular Disease Stroke Strokes Risk Factors 40

Frontiers in Cardiovascular Medicine

JANUARY 21, 2024

Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL).

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease Coronary Artery Disease 45

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111